Klotho Neurosciences, Inc. (KLTO) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.98 (-0.50%), Market cap $0.06B, 52-week low–high $0.17 ~ $2.01.
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Financial statements, price targets, institutional (13F) holdings and related news for Klotho Neurosciences, Inc. are updated in real time on BlackAll Trade.
Klotho Neurosciences, Inc. trades at $2.98 (-0.50%). Real-time quotes and charts are available on BlackAll Trade.
Klotho Neurosciences, Inc. has a market cap of about $0.06B.
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatme